The kinetics of activation of the respiratory burst oxidase in the cell-free oxidase-activating system have been explained by a three-stage mechanism in which the membrane-associated oxidase components M: (a) take up a cytosolic factor S to form a complex M S that is (b) 48-kD proteins that are missing in certain forms of CGD, and that other forms of type II CGD besides the one described in this report remain to be discovered.
Introduction
The respiratory burst oxidase is the enzyme chiefly responsible for the production of microbicidal oxidants by neutrophils and other professional phagocytes. It is a membrane-bound oxidase, dormant in resting cells, that catalyzes the reduction of oxygen to superoxide (0°) at the expense of NADPH (1) : 202 + NADPH --2 0°+ NADP+ + HW. Recent investigations using a cell-free oxidase-activating system have shown it to be a complex species requiring for the expression of its activity a number of components, some from the plasma membrane (2-6) and others from the cytosol (2, 3, 7-16).
Chronic granulomatous disease (CGD)' is an inherited disorder characterized by the inability of phagocytes from af-fected patients to manufacture microbicidal oxidants because of a defect in the respiratory burst oxidase or its activating apparatus (17) . It has been shown over the past few years that CGD can be classified into several distinct types based on mode of inheritance, on whether or not a membrane-associated heme protein known as cytochrome b558 is present in the affected phagocytes (18) (19) (20) , and on whether the functionally abnormal component resides in the cytosol or the membrane of the defective phagocyte (3, 6, 8, 20, 21) . With regard to those forms ofCGD caused by membrane defects, the genes for both the 91-and 22-kD subunits of the cytochrome have now been cloned (22, 23), and Dinauer et al. showed that X-linked cytochrome-negative CGD, the most common type, is associated with a lesion involving the gene encoding the larger subunit (24) . Defects in cytosol-based components were first demonstrated by Curnutte et al., who showed that cytosols from seven patients with autosomal recessive cytochrome-positive type of CGD (type II CGD (Scripps classification [20] )) failed to support 0°production in the cell-free oxidase-activating system (21). We now present evidence that the biochemical defect in two patients with type II CGD involves a cytosolic protein that participates at an early stage in the activation of the oxidase.
Methods
Cells from both normal subjects and CGD patients were obtained by leukapheresis after obtaining informed consent. Dexamethasone (4-mg doses 12 and 2 h before the start ofpheresis) was given to normal donors to augment neutrophil yields; this treatment did not alter the properties of subcellular fractions prepared from the cells. Purification of neutrophils was subsequently carried out as described before (25) , except that dextran sedimentation was omitted. Neutrophil yields were 0.6-2.2 X 1010 cells/donor. Cells were disrupted by nitrogen cavitation and cytosol and solubilized membranes were prepared from the neutrophil cavitates according to a published method (2, 3) , solubilizing the membranes in Na deoxycholate at a final detergent concentration of 1.6% (wt/vol) in buffer containing 25% (vol/vol) glycerol and other constituents as previously described (6) . Protein concentrations of these fractions were previously determined to be as follows (2) : cytosol, 250±16 SE g/l07 cell eq; solubilized membranes, 25.7±1.4 SE ,ug/10' cell eq. The cytosol preparations always contained 9 X 107 cell eq/ml.
O2 production was assayed as described elsewhere (2) , except that the membranes were incubated for 3.5 min with cytosol or buffer, SDS, and Mg2e in the absence of NADPH to preactivate the oxidase before the addition of the reducing agent, and the cytochrome c concentration in the assay mixture was 0.15 mM. Preliminary experiments showed that in the presence of normal cytosol the oxidase was nearly fully activated during the 3.5-min preincubation and that its activity did not decline over the next 1.5 min. The maximum rate of O2 production (VOO previously referred to as V [2] (Fig. 1) . The mixtures containing the CGD cytosols yielded little oxidase activity at any of the concentrations tested. In contrast, oxidase activity as a function of normal cytosol concentration showed the usual sigmoidal curve (2) , with greater-than-first-order kinetics at low levels of cytosol and a long plateau that appears as the cytosol concentration begins to exceed the concentration of neutrophil membranes (both expressed in terms of cell equivalents).
The lag. The components ofthe cell-free oxidase-activating system include detergent, Mg2+, and cytosol and plasma membrane from resting neutrophils. When the oxidase in this system is activated in the presence of substrate (i.e., NADPH), the early course of the 02-forming reaction is characterized by a lag that reflects the time required to convert the dormant oxidase to its active form (2, 6) . We have previously shown that this lag can be abolished by incubating the components together for several minutes before adding NADPH to the assay mixture (2, 3 (1, 6, 17] ) that was generated at high cytosol concentrations. We have now confirmed this result at three cytosol concentrations (Table II) , showing a statistically significant difference in the Km for NADPH between the oxidase generated at the lowest concentration of cytosol and the oxidase formed at each of the two higher cytosol concentrations (P < 0.002 for each difference). To determine whether type II CGD cytosol, though unable to activate the oxidase, was capable of supporting the formation of the ordinary (i.e., low K.) as opposed to the low-activity (i.e., high K.) enzyme, an experiment was performed in which the Km ofoxidase generated at a low cytosol concentration was compared with the Km observed when the low-cytosol activating system was supplemented with additional cytosol, either normal or type II CGD. The results (Table III) The low-and high-affinity forms of the respiratory burst oxidase were generated as described in Table II using either a low (4 X 106 cell eq/reaction) or high (16.6 X 106 cell eq/reaction) concentration of normal cytosol, respectively. Where indicated, cytosol from one of the two type II CGD patients (J.C. and J.G.) was included in the activation mixture at 12.6 X 106 cell eq/reaction. The kinetic parameters were calculated as described in Table II . The results of a single experiment using cytosols from both CGD patients are shown. Similar results were obtained in a second experiment using cytosol from patient J.G. only. In reaction mixtures containing patient cytosols only, O2 was produced at < 1% of the rate seen with normal cytosols incubated under identical conditions. activation mixture was so small that without such supplementation only the low-activity oxidase was produced.
The order ofthe oxidase-activating reaction. During the lag phase of the reaction catalyzed by the cell-free activation system, the rate of production of O2 makes an asymptotic approach to a constant final velocity (Va., as defined in Methods) that represents the rate ofO°production when all the dormant oxidase has been converted to its catalytically active form. VOO is thus directly proportional to the concentration of catalytically competent oxidase at full activation. In the earlier kinetic study, V,, (i.e., the concentration of active oxidase) was estimated to vary with the square of the cytosol concentration, although the true value of the slope of the line from which this estimate was made (a plot of log VO. vs. log cytosol concentration) was actually 2.3. We now have measured V,. as a function of cytosol concentration with preparations from seven additional normal subjects, and have found the slopes of the log-log plots derived from these results to be 2.52±0.09 SE (see representative plots [normal] in Fig. 3, A and B) . Similar slopes were obtained using cytosols from each of the three types of CGD in which the defect resides, not in the cytosol, but in the neutrophil membrane (types I, III, and IV; data not shown) (3, 6, 8, 20) . We therefore conclude that with respect to the cytosol, the order of the reaction that determines the concentration of oxidase after activation is complete is not 2, as previously reported, but 2.5.
If we are correct in our supposition that multiple components in the cytosol are required for oxidase activity, and if only one of these components is defective in type II CGD while the others are normal, then it would be expected that the reaction order as measured with normal cytosol would be decreased ifthe measurements were carried out in the presence of excess type II CGD cytosol, because of the normal components that would be contributed to the assay mixtures by the defective cytosol. When this experiment was conducted, it was found that the slope of the log-log plot fell to 0.99±0.04 SE (n = 3; Fig. 3 ). This result provides additional evidence for the occurrence in the cytosol of multiple components necessary for oxidase activity, and is consistent with the idea that the component missing from type II CGD cytosol normally contributes one order to the reaction that determines the concentration ofoxidase in the fully activated system-i.e., that in the normal cell-free activation system, the concentration of oxidase after full activation is directly proportional to the concentration of the component missing from the cytosol of the type II CGD patients' neutrophils.
Complementation. From the foregoing observations, it can be inferred that in the cytosols from J.G. and J.C. the same component is defective. This inference was further tested by complementation studies in which the oxidase-activating capacity of mixtures of the two defective cytosols was examined. In an assay mixture containing equal volumes of the two cytosols, each and that with neutrophil cytosols from at least some of these other types, the lag in O2 production characteristic of the cellfree activating system will be eliminated by preincubation in the absence of NADPH. This latter idea has recently been borne out with the discovery of a patient with type II CGD whose neutrophils show a cytosol defect that is corrected by the CGD cytosols studied in this investigation (28) .
